FDA To Pilot "Real-Time" Meetings For 510(k) Supplement Reviews
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers will have the option to engage FDA in "real-time" meetings to discuss resubmitted 510(k) supplement applications under a pilot scheduled to commence in the next two weeks, FDA staffers say.